Dysregulated renin-angiotensin-aldosterone system contributes to pulmonary arterial hypertension (Q37408132)

20 August 2017

Dysregulated renin-angiotensin-aldosterone system contributes to pulmonary arterial hypertension (English)

1 reference

20 August 2017

arterial hypertension

0 references

16

Marc Humbert

1 reference

20 August 2017

9

Gérald Simonneau

1 reference

20 August 2017

Anton Vonk-Noordegraaf

15

object named as

Anton Vonk-Noordegraaf

1 reference

20 August 2017

10

Elie Fadel

1 reference

20 August 2017

17

Saadia Eddahibi

1 reference

20 August 2017

Christophe Guignabert

18

object named as

Christophe Guignabert

1 reference

20 August 2017

12

Anco Boonstra

1 reference

20 August 2017

Frances S de Man

1

1 reference

20 August 2017

Ly Tu

2

1 reference

20 August 2017

M Louis Handoko

3

1 reference

20 August 2017

Silvia Rain

4

1 reference

20 August 2017

Gerrina Ruiter

5

1 reference

20 August 2017

Charlène François

6

1 reference

20 August 2017

Ingrid Schalij

7

1 reference

20 August 2017

Peter Dorfmüller

8

1 reference

20 August 2017

Frederic Perros

11

1 reference

20 August 2017

Piet E Postmus

13

1 reference

20 August 2017

Jolanda van der Velden

14

1 reference

20 August 2017

language of work or name

English

0 references

publication date

2 August 2012

1 reference

American Journal of Respiratory and Critical Care Medicine

20 August 2017

1 reference

20 August 2017

186

1 reference

20 August 2017

8

1 reference

20 August 2017

780-789

1 reference

Autocrine fibroblast growth factor-2 signaling contributes to altered endothelial phenotype in pulmonary hypertension

20 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5104838

Perspectives on novel therapeutic strategies for right heart failure in pulmonary arterial hypertension: lessons from the left heart.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5104838

The angiotensin-converting enzyme 2/angiogenesis-(1-7)/Mas axis confers cardiopulmonary protection against lung fibrosis and pulmonary hypertension

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5104838

Physiology of kidney renin

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5104838

Tissue renin-angiotensin-aldosterone systems: Targets for pharmacological therapy

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5104838

Polymorphism in the angiotensin II type 1 receptor (AGTR1) is associated with age at diagnosis in pulmonary arterial hypertension

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5104838

Evidence for angiotensin-converting enzyme 2 as a therapeutic target for the prevention of pulmonary hypertension.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5104838

Endothelial-derived FGF2 contributes to the progression of pulmonary hypertension in humans and rodents

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5104838

Hyponatremia predicts right heart failure and poor survival in pulmonary arterial hypertension

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5104838

Angiotensin-converting enzyme 2 and new insights into the renin-angiotensin system

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5104838

Emerging concepts of regulation of angiotensin II receptors: new players and targets for traditional receptors

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5104838

Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5104838

Physiology of local renin-angiotensin systems.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5104838

Angiotensin II type 1 receptor blockers

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5104838

Haemodynamic and hormonal effects of captopril in primary pulmonary hypertension

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5104838

Role of neurohormonal mechanisms in determining survival in patients with severe chronic heart failure

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5104838

Opposite effects of training in rats with stable and progressive pulmonary hypertension.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5104838

Angiotensin receptor antagonists: focus on losartan

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5104838

Medical therapy can improve the biological properties of the chronically failing heart. A new era in the treatment of heart failure

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5104838

Cardioprotective effects of ramipril and losartan in right ventricular pressure overload in the rabbit: importance of kinins and influence on angiotensin II type 1 receptor signaling pathway

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5104838

Progressive right ventricular dysfunction in patients with pulmonary arterial hypertension responding to therapy

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5104838

Survival in patients with idiopathic, familial, and anorexigen-associated pulmonary arterial hypertension in the modern management era.

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5104838

Src tyrosine kinase regulates angiotensin II-induced protein kinase Czeta activation and proliferation in vascular smooth muscle cells

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5104838

Effects of telmisartan on right ventricular remodeling induced by monocrotaline in rats

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5104838

Prevention of pulmonary vascular remodeling and of decreased BMPR-2 expression by losartan therapy in shunt-induced pulmonary hypertension

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5104838

Angiotensin-converting enzyme DD genotype in patients with primary pulmonary hypertension: increased frequency and association with preserved haemodynamics.

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5104838

Neurohormonal activation in patients with right ventricular failure from pulmonary hypertension: Relation to hemodynamic variables and endothelin levels

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5104838

Captopril in primary pulmonary hypertension.

2 September 2018

1 reference

Crossref

https://api.crossref.org/works/10.1164%2FRCCM.201203-0411OC

Diaphragm Muscle Fiber Weakness in Pulmonary Hypertension

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1164%2FRCCM.201203-0411OC

Short- and long-term hemodynamic effects of captopril in patients with pulmonary hypertension and selected connective tissue disease

21 January 2018

1 reference

12 December 2020

Prognostic significance of sympathetic nervous system activation in pulmonary arterial hypertension

1 reference

12 December 2020

Expression of pulmonary vascular angiotensin-converting enzyme in primary and secondary plexiform pulmonary hypertension

1 reference

12 December 2020

Increased sympathetic nerve activity in pulmonary artery hypertension

1 reference

12 December 2020

Bisoprolol Delays Progression Towards Right Heart Failure in Experimental Pulmonary Hypertension

1 reference

12 December 2020

Angiotensin II signaling in vascular smooth muscle. New concepts

1 reference

12 December 2020

Effects of exercise training in patients with idiopathic pulmonary arterial hypertension

1 reference

12 December 2020

10.1164/RCCM.201203-0411OC

Identifiers

DOI

1 reference

20 August 2017

1 reference

20 August 2017

PubMed publication ID

22859525

1 reference